Sortera Bio

Cambridge, United Kingdom

Sortera Bio operates as a biotechnology company.

$10.2M raised

Jun 2025

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sortera Bio raised?

Sortera Bio has raised $10.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2025.

Who are Sortera Bio's investors?

Sortera Bio's investors include AstraZeneca, Cambridge Innovation Capital, BioNTech.

Where is Sortera Bio headquartered?

Sortera Bio is headquartered in Cambridge, United Kingdom.

What does Sortera Bio do?

Sortera Bio operates as a biotechnology company.

What stage is Sortera Bio at?

Sortera Bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 5, 2025.

MLA

"Sortera Bio — Funding & Investors." VCBacked, June 5, 2025, https://www.vcbacked.co/company/sortera-bio. Accessed July 3, 2026.

APA

VCBacked. (2025). Sortera Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/sortera-bio

Wikipedia (cite web)

{{cite web |title=Sortera Bio — Funding & Investors |url=https://www.vcbacked.co/company/sortera-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 5, 2025.